C78.89
Secondary malignant neoplasm of other digestive organs
Clinical Classification Guidelines
Code Also
- exocrine pancreatic insufficiency (K86.81)
Medical Intelligence & Overview
Secondary malignant neoplasm of other digestive organs, classified under ICD-10 code C78.89, refers to cancer that has spread (metastasized) from its original site to other parts of the digestive system. Unlike primary cancers that originate in a specific organ, secondary neoplasms result from the spread of malignant cells through the bloodstream or lymphatic system. This condition indicates an advanced stage of cancer and requires comprehensive medical evaluation and treatment planning.
Causes & Symptoms
Clinical Causes: Primary cancer originating in one of the digestive organs such as stomach, pancreas, liver, or intestines, which then spreads to other digestive structures. Metastatic dissemination through lymphatic channels or bloodstream from a primary site elsewhere in the body. Increased likelihood in individuals with a history of digestive system cancers or other malignancies prone to metastasize to abdominal organs.
Key Symptoms: Unexplained weight loss Persistent abdominal pain or discomfort Swelling or bloating of the abdomen Changes in bowel habits, such as diarrhea or constipation Nausea or vomiting Loss of appetite Jaundice (yellowing of the skin and eyes), if liver involvement occurs Fatigue and weakness
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of medical history review, physical examination, and various diagnostic procedures such as:
Treatment Protocols: Treatment strategies depend on the extent of spread, patient's overall health, and specific involved organs. Common approaches include:
Clinical Advice & FAQs
Billing Guidance
Is C78.89 a billable ICD-10 code?
Yes, C78.89 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C78.89?
Clinical documentation must specify the nature of Secondary malignant neoplasm of other digestive organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference